Cartesian Therapeutics Inc (RNAC)

Other Income/Expenses (Net)

$44.92M

Quarterly · Period ending: · USD

RNAC logo

RNAC Other Income/Expenses (Net)

Latest reported$44.92M
RNAC Quarterly Other Income/Expenses (Net) ($77.00K → $44.92M)
High-resolution chart · PNG

RNAC other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
44,924,000
-12,683,000
-79,830,000
-14,836,000
37,697,000
4,179,000
16,765,000
-6,608,000
79,000
-43,476,000
-160,326,000
4,063,000
7,251,000
-3,282,000
14,101,000
-6,615,000
-5,259,000
18,005,000
8,299,000
-97,000
4,113,000
-17,439,000
-7,548,000
4,005,000
-7,714,000
-798,000
-2,318,000
-200,000
-159,000
-218,000
-152,000
-60,000
-27,000
-75,000
-267,000
-822,000
-96,000
-352,000
-223,000
-260,000
-522,000
-535,000
258,000
346,000
-551,000
77,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.